FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from ...

If you're not over 65 or have certain risk factors, it might be hard to get one but not necessarily impossible. Here's what ...

Carlsbad’s Ionis Pharmaceuticals, a biotechnology company, has developed many drugs approved for the treatment of ...